#7
Beam Therapeutics
The $2B base editing pioneer co-founded by Eric Lander. Base editing corrects single-letter DNA errors without cutting the double helix, offering precision that outperforms CRISPR Therapeutics' standard CRISPR by reducing off-target edits by 95% in recent studies. This platform is applicable to thousands of genetic diseases.
Photos (1)
Comments on "Beam Therapeutics"
Create a free account or sign in to join the discussion.
Sign in to join the conversation